OrthoPediatrics (NASDAQ:KIDS) Hits New 12-Month Low – Time to Sell?

OrthoPediatrics Corp. (NASDAQ:KIDS)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as $23.97 and last traded at $23.97, with a volume of 65270 shares trading hands. The stock had previously closed at $24.98.

Analysts Set New Price Targets

KIDS has been the subject of a number of research analyst reports. Needham & Company LLC reissued a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Friday. Truist Financial cut their price target on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a report on Monday, October 14th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Friday, September 13th.

OrthoPediatrics Trading Down 3.8 %

The company has a 50 day simple moving average of $27.62 and a 200 day simple moving average of $29.76. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.96 and a current ratio of 4.90. The company has a market capitalization of $582.01 million, a PE ratio of -20.31 and a beta of 1.16.

Insiders Place Their Bets

In other news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $29.30, for a total value of $293,000.00. Following the completion of the sale, the general counsel now directly owns 77,304 shares in the company, valued at $2,265,007.20. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 31.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in shares of OrthoPediatrics by 1.3% in the first quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock valued at $25,772,000 after acquiring an additional 11,100 shares in the last quarter. AWM Investment Company Inc. boosted its position in shares of OrthoPediatrics by 14.6% in the 1st quarter. AWM Investment Company Inc. now owns 487,619 shares of the company’s stock valued at $14,219,000 after purchasing an additional 62,000 shares during the period. Harbor Capital Advisors Inc. raised its stake in OrthoPediatrics by 268.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company’s stock valued at $6,692,000 after acquiring an additional 179,803 shares during the last quarter. Paradigm Capital Management Inc. NY raised its stake in OrthoPediatrics by 8.0% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 134,400 shares of the company’s stock valued at $3,865,000 after acquiring an additional 10,000 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in OrthoPediatrics by 2.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 132,434 shares of the company’s stock valued at $3,590,000 after acquiring an additional 2,661 shares during the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.